RICE: Remission by Intra-articular Injection Plus CErtolizumab
Status:
Completed
Trial end date:
2018-01-15
Target enrollment:
Participant gender:
Summary
Tight control of an adaptive concomitant treatment strategy after initiation of CZP will lead
to an improved outcome of RA patients with an active disease despite DMARD treatment.